tried half-life for 17 weeks. here is what happened.
I have had 17 orders now and I keep a table, so here is the honest summary rather than a vibe. Material has been consistent. Communication has not. Shipping has varied by about 14 days on nominally the same lane, which matters more in summer than in February. The independent number came back 96.8% against a claimed…
do not extrapolate rodent data to human dosing without saying so
receptor distribution matters, GLP-1 is not everywhere
do not extrapolate rodent data to human dosing without saying so
Adding to this: pharmacology is doing more work than the comment implies.
This is correct. Rodent data is investigational, not predictive.
amylin is not GLP-1, posts conflating them get corrected
the half-life is mechanism, affects steady state timing
amylin is not GLP-1, posts conflating them get corrected
Not to be pedantic but pharmacology and mechanism are being used interchangeably and they are not interchangeable in real life.
Rodent, human, or in vitro?
That is net peptide content, not purity. Different number, different meaning.
do not extrapolate rodent data to human dosing without saying so